These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22529225)

  • 1. The psychopharmacological management of RLS in psychiatric conditions: a review of the literature.
    Cuellar NG
    J Am Psychiatr Nurses Assoc; 2012; 18(4):214-25. PubMed ID: 22529225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mood disorders in restless legs syndrome (Willis-Ekbom disease).
    Becker PM; Sharon D
    J Clin Psychiatry; 2014 Jul; 75(7):e679-94. PubMed ID: 25093484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restless Legs Syndrome and Psychiatric Disorders.
    Mackie S; Winkelman JW
    Sleep Med Clin; 2015 Sep; 10(3):351-7, xv. PubMed ID: 26329445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric comorbidity in children and adolescents with restless legs syndrome: a retrospective study.
    Pullen SJ; Wall CA; Angstman ER; Munitz GE; Kotagal S
    J Clin Sleep Med; 2011 Dec; 7(6):587-96. PubMed ID: 22171196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis.
    Hankin C; Lee D; Garcia-Borreguero D; Wang Z
    J Clin Sleep Med; 2019 Sep; 15(9):1225-1232. PubMed ID: 31538593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regular intake of non-opioid analgesics is associated with an increased risk of restless legs syndrome in patients maintained on antidepressants.
    Leutgeb U; Martus P
    Eur J Med Res; 2002 Aug; 7(8):368-78. PubMed ID: 12204845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood.
    Montagna P; Hornyak M; Ulfberg J; Hong SB; Koester J; Crespi G; Albrecht S
    Sleep Med; 2011 Jan; 12(1):34-40. PubMed ID: 20965780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restless legs syndrome: a review of diagnosis and management in primary care.
    Bogan RK; Cheray JA
    Postgrad Med; 2013 May; 125(3):99-111. PubMed ID: 23748511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
    Pourcher E; Rémillard S; Cohen H
    J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is nocturnal eating in restless legs syndrome linked to a specific psychopathological profile? A pilot study.
    Marconi S; Scarlatti F; Rizzo G; Antelmi E; Innamorati M; Pompili M; Brugnoli R; Belvederi Murri M; Amore M; Provini F
    J Neural Transm (Vienna); 2015 Nov; 122(11):1563-71. PubMed ID: 26233564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restless Legs Syndrome: Psychiatric Comorbidities Are More Important Than Neuroticism.
    Trautmann E; Barke A; Frisch JU; Schmidt AL; Kunert F; Canelo M; Sixel-Döring F; Trenkwalder C
    Behav Sleep Med; 2015; 13(5):375-86. PubMed ID: 24945565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restless legs syndrome.
    Ondo WG
    Neurol Clin; 2009 Aug; 27(3):779-99, vii. PubMed ID: 19555831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ropinirole treatment for restless legs syndrome.
    Bogan RK
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Restless legs syndrome and depression].
    Rasmussen J; Videbech P
    Ugeskr Laeger; 2011 Aug; 173(35):2113-7. PubMed ID: 21884661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and novel treatment approaches in restless legs syndrome: II. Treatment].
    Hirata K; Suzuki K
    Brain Nerve; 2013 Nov; 65(11):1391-9. PubMed ID: 24200617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical correlates of restless legs syndrome among psychogeriatric patients.
    Agüera-Ortiz L; Perez MI; Osorio RS; Sacks H; Palomo T
    Int J Geriatr Psychiatry; 2011 Dec; 26(12):1252-9. PubMed ID: 21748800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of non-ergot dopamine agonists on health-related quality of life of patients with restless legs syndrome.
    Talati R; Phung OJ; Mather J; Coleman CI
    Ann Pharmacother; 2009 May; 43(5):813-21. PubMed ID: 19401472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.